How does Vivos' oral appliance therapy differ from CPAP?

Unlike CPAP, which manages sleep apnea symptoms by delivering pressurized air, Vivos' oral appliance technology aims to physically remodel the airway by repositioning and redeveloping the jaws. This approach targets the underlying craniofacial structure rather than simply addressing nightly symptoms. Over time, patients may reduce or eliminate their dependence on CPAP altogether.

Is Vivos' oral appliance therapy covered by insurance?

The episode addresses insurance coverage as part of the treatment discussion, noting it as a key consideration for patients. Coverage can vary depending on the patient's plan and diagnosis. Prospective patients are encouraged to consult with a Vivos-trained provider to understand their specific coverage options.

Why are sleep apnea rates rising in modern populations?

Kirk Huntsman explains that a combination of environmental, genetic, and lifestyle factors has led to narrower airways in modern populations, increasing the prevalence of obstructive sleep apnea. Changes in diet, jaw development during childhood, and posture all contribute to craniofacial underdevelopment. These structural issues reduce airway size and increase the risk of airway obstruction during sleep.

The Future of Sleep Apnea Treatment: Vivos’...

The Future of Sleep Apnea Treatment: Vivos’ Oral Appliance Technology Offers an Alternative to CPAP

This episode of I Don't Care explores how Vivos Therapeutics' oral appliance technology offers an alternative to CPAP by physically remodeling the airway through jaw repositioning and craniofacial development. Host Kevin Stevenson and Vivos CEO Kirk Huntsman discuss why modern populations are increasingly prone to obstructive sleep apnea and how a dental-based, non-surgical approach can reduce or eliminate CPAP dependence. The conversation covers treatment timelines, insurance coverage, and long-term patient outcomes.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · September 24, 2025, 11:00 AM UTCAirway RemodelingCpapDr. Kevin StevensonKirk Huntsman

Key takeaways

Vivos Therapeutics' oral appliances remodel the airway by repositioning and redeveloping the jaws, potentially reducing CPAP dependence.

Environmental, genetic, and lifestyle factors have contributed to narrower airways in modern populations, driving the rise of obstructive sleep apnea.

Sleep apnea is linked to nearly every major chronic disease, making early, effective treatment critical to long-term health outcomes.

Obstructive sleep apnea affects a whopping 30 million Americans, yet millions remain undiagnosed or abandon CPAP therapy due to its discomfort and inconvenience. Recent innovations in oral appliance therapy, however, are opening up new possibilities for patients seeking safe, effective, and lasting solutions. With sleep apnea linked to virtually every chronic disease—from heart disease to diabetes—the stakes couldn’t be higher.

So, what if there were a way to actually remodel the airway and reduce dependence on CPAP altogether? Could a non-surgical, dental-based approach reshape the future of sleep apnea treatment?

Welcome to I Don’t Care. In the latest episode, host Dr. Kevin Stevenson speaks with R. Kirk Huntsman, Chairman and CEO of Vivos Therapeutics. Together, they explore how airway remodeling through oral appliances may offer patients an alternative to CPAP, why craniofacial development is so central to sleep disorders, and how innovations in treatment are changing lives across the country.

In this episode, you’ll learn:

How Vivos Therapeutics’ oral appliance technology works by repositioning and redeveloping the jaws to create wider, more functional airways.

Why environmental, genetic, and lifestyle factors have led to narrower airways in modern populations—and how this contributes to the rise of sleep apnea.

What patients can expect in terms of treatment timelines, insurance coverage, and long-term outcomes, including reducing or eliminating dependence on CPAP.

R. Kirk Huntsman is a seasoned healthcare entrepreneur with over 35 years of experience founding and leading companies in dental practice management, medical devices, and healthcare services. He built and scaled Dental One, Inc. into a $70M business before its sale, and later co-led the merger that created DentalOne Partners, operating over 150 practices nationwide. Currently Chairman and CEO of Vivos Therapeutics, he focuses on strategic growth, capital acquisition, and innovative technologies to advance treatment for sleep and airway disorders.

Article written by MarketScale.